trending Market Intelligence /marketintelligence/en/news-insights/trending/rffno8i_b8mthvebdm0yba2 content esgSubNav
In This List

NeoGenomics prices common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


NeoGenomics prices common stock offering

NeoGenomics Inc. priced an underwritten public offering of 9,800,000 common shares at $12.75 each.

The Fort Myers, Fla.-based operator of cancer-focused genetic testing laboratories expects to raise gross proceeds of about $125 million.

Underwriters have a 30-day option to buy up to 1,470,000 additional common shares at the offering price.

The company expects the offering to close on or about Aug. 14, subject to customary closing conditions.

Net proceeds will be used to grow NeoGenomics' business through potential acquisitions and investments. Funds may also go toward working capital and general corporate purposes.

William Blair and Leerink Partners are acting as joint book-running managers for the offering, with Craig-Hallum Capital Group, Stephens Inc., First Analysis Securities Corp., Janney Montgomery Scott and The Benchmark Co. LLC as co-managers.